Regenxbio (RGNX) Retained Earnings (2014 - 2025)
Regenxbio's (RGNX) quarterly Retained Earnings came in at -$687000.0 in Q4 2025, up 7.29% year-on-year from -$640335.8 in Q4 2024, and down 5.37% quarter-over-quarter from -$652000.0 in Q3 2025.
Regenxbio (RGNX) Retained Earnings (2014 - 2025) Analysis & Trends
Regenxbio's Retained Earnings history runs 12 years deep, the most recent figure standing at -$687000.0 for Q4 2025.
- On a quarterly basis, Retained Earnings rose 7.29% year-over-year to -$687000.0 in Q4 2025; TTM through Dec 2025 was -$687000.0, a 7.29% increase from a year earlier, with the FY2025 full-year figure at -$687000.0, up 7.29% from the prior year.
- Retained Earnings eased to -$687000.0 in Q4 2025 per RGNX's latest filing, from -$652000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at -$652000.0 in Q3 2025 and bottomed at -$996.9 million in Q2 2025.
- The 5-year median for Retained Earnings is -$389.2 million (2021), against an average of -$360.1 million.
- Across the five-year window, Retained Earnings sank 53020.0% in 2021 and soared 99.93% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$2.6 million in 2021, then slumped by 17087.74% to -$441.6 million in 2022, then slumped by 59.67% to -$705.0 million in 2023, then jumped by 99.89% to -$741000.0 in 2024, then rose by 7.29% to -$687000.0 in 2025.
- Per Business Quant, the three latest RGNX Retained Earnings figures stand at -$687000.0 (Q4 2025), -$652000.0 (Q3 2025), and -$996.9 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -622,000.00 |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn | -687,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -687,000.00 |
| Sep 30, 2025 | -652,000.00 |
| Jun 30, 2025 | -996.90 Mn |
| Mar 31, 2025 | -926.07 Mn |
| Dec 31, 2024 | -741,000.00 |
| Sep 30, 2024 | -880.96 Mn |
| Jun 30, 2024 | -821.37 Mn |
| Mar 31, 2024 | -3.23 Mn |
| Dec 31, 2023 | -705.05 Mn |
| Sep 30, 2023 | -642.20 Mn |
| Jun 30, 2023 | -10.10 Mn |
| Mar 31, 2023 | -508.20 Mn |
| Dec 31, 2022 | -441.55 Mn |
| Sep 30, 2022 | -381.60 Mn |
| Jun 30, 2022 | -14.76 Mn |
| Mar 31, 2022 | -11.95 Mn |
| Dec 31, 2021 | -2.57 Mn |
| Sep 30, 2021 | -455.26 Mn |
| Jun 30, 2021 | -396.90 Mn |
| Mar 31, 2021 | -1.37 Mn |